Questions to Ask a Cord Blood Bank (+ 3 Red Flags)

Cord Blood Banking

At MiracleCord, we believe an informed customer is the best customer. When you’re comparing cord blood banks, it’s important to know what questions to ask — and to have some context for the answers. Here, we’ve compiled the top questions — along with some red flags — to help you make an informed decision and invest wisely in your family’s future.

Questions to Ask a Cord Blood Bank

  1. Is your lab AABB accredited, FDA registered, and CLIA certified?
  2. How long have you been in business?
  3. What is your Google reviews rating?
  4. Is your collection kit FDA-approved and temperature controlled?
  5. What tests are run on maternal blood samples?
  6. What would make my newborn’s stem cells non-viable for storage?
  7. How quickly are the stem cells processed following collection?
  8. What method is used to process the cord blood and cord tissue?
  9. Are the stem cells stored in a compartmentalized storage bag?
  10. Where do you store the stem cells?
  11. What happens if I need to use my stem cells but already paid for long-term storage?
  12. What happens if my cord blood does not get collected or can’t be saved?
  13. Do you offer incentives to medical professionals to recommend you?
  14. Do you offer a guarantee if my saved stem cells fail to engraft?
  15. Do you offer cord blood banking discounts for return clients?
  16. Is there a fee to access my stored stem cells?
  17. Will you ever raise my annual storage fees?
  18. Is it important that a cord blood bank sponsor clinical trials?

Red Flags

  1. The cord blood bank offers placental tissue banking
  2. The cord blood bank has hidden fees
  3. The cord blood bank has low monthly fees, but they are new and have no experience

Business Basics

Choose a cord blood bank that is accredited, has a proven track record, positive reviews, and is financially stable.

1. Is your lab AABB accredited, FDA registered, and CLIA certified?

AABB Accredited

Your cord blood bank’s lab should be accredited by the American Association of Blood Banks (AABB). A lab facility with AABB-accreditation for banking cord blood adheres to the industry’s most stringent standards for processing and storing cord blood stem cells.

Some banks are fee-paying members of the AABB, but that’s not the same as being fully accredited. To be accredited, the cord blood banking company must have its laboratory and administrative procedures reviewed, inspected, and validated regularly, and their procedures must comply with the AABB guidelines.

FDA Registered

All cord blood banks that operate within the U.S. must be FDA registered. FDA requirements include establishment registration and listing, donor screening and testing for infectious diseases (except when used for the original donor), reporting and labeling requirements, and compliance with current good tissue practice regulations [*]. Registered establishments are subject to FDA inspection to ensure they are compliant and to prevent infectious disease transmission.

CLIA Certified

CLIA stands for Clinical Laboratory Improvement Amendments, a set of federal laws passed in 1988 to create standards for any laboratory that performs any patient testing. Labs that are registered with CLIA get inspected every two years. The cost of CLIA validation is paid by the laboratory and the program is managed by the US Centers for Medicare & Medicaid Services (CMS) [*].

MiracleCord’s lab is AABB accredited, FDA registered, and CLIA Certified.

2. How long have you been in business?

Stability is important; There are many startups in the industry now looking to entice customers with low rates or other gimmicks that are simply not sustainable. As a general rule, look for companies that have at least 10 years’ experience and a proven ability to get the job done right. Ask them how many units have been released for transplant and if any failed to engraft.

It may also be worth asking if the company is publicly or privately held. Being publicly held is not the same as being a public cord blood bank that accepts donations. Some of the largest private cord blood banks are publicly held companies that answer to shareholders and their desire for ever higher profit margins, and they may be frequently bought and sold, leading to leadership changes.

MiracleCord is a privately held, financially stable company whose lab has been processing and storing cord blood for more than 25 years. To date, more than 100 stored stem cell units have been released from our lab facility. All units released for transplant by MiracleCord have engrafted successfully.

3. What is your Google reviews rating?

To understand what your experience may be like as a customer, take the time to read unsolicited customer reviews from all cord blood banks you’re considering using.

MiracleCord has a 5-star rating from Google reviews.

Collection Kit & Processing

How the stem cells are collected, processed and the time to process are critical to ensuring you get the most viable stem cells from your baby’s cord blood and tissue.

4. Is your collection kit FDA-approved and temperature controlled?

You only get one chance to harvest these precious cells, so the cord blood collection kit matters. You’ll want to make sure the kit:

  • Uses a sterile, FDA-approved cord blood collection bag that can also be used within the sterile field in the event a C-section is required.
  • Uses Citrate Phosphate Dextrose (CPD), an FDA-recommended anticoagulant and cell preservative, in the collection bag instead of heparin. CPD collection bags have been proven to increase stem cell yield by more than 50% compared to heparin collection bags, and CPD is recommended by the U.S. Department of Health and Human Services for cord blood collection.
  • Protects the cord blood and tissue from ambient temperature fluctuations while enroute to the laboratory.
  • Is sufficiently robust to prevent any damage to contents.
  • Is transported by medical courier only to minimize the potential for damage and expedite the transport.
  • Includes detailed collection instructions for the medical professional.

MiracleCord’s StemCare® Collection Kit is among the industry’s best, meeting all of the above requirements. We also employ a next-flight-out medical courier that is available 24/7/365. This is included with every plan, at no additional cost, to ensure your collection kit gets to our lab quickly and safely.

5. What tests are run on maternal blood samples?

The AABB and FDA require several clinical tests to be performed on cord blood, cord tissue, and maternal blood at the time of initial processing [*].

To prevent the spread of infectious diseases, maternal blood samples are collected and tested for infections such as Hepatitis B and C, HIV, HTLV (Human T-Lymphotropic Virus Types I/II), cytomegalovirus, West Nile virus and Syphilis.

If the maternal blood draw detects the presence of an infectious disease, it’s possible you or your baby will require additional testing or treatment, but it typically will not affect the utility of the umbilical cord blood sample.

Some cord blood banks forego critical testing procedures that may ultimately limit your family’s ability to use your baby’s stem cells in the future. Without these tests, the FDA may restrict your child’s stem cells from being released and used for transplant.

MiracleCord performs all required testing during initial processing to ensure compliance with AABB standards and FDA guidelines.

6. What would make my newborn’s stem cells non-viable for storage?

There can be situations where the utility of the cord blood is rendered useless due to a latent disease or condition with the baby, such as Down syndrome, but this is very rare. There can also be circumstances where there is not enough cord blood collected to process. It’s also pretty rare these days, even with preterm infants.

At MiracleCord, we always want the collecting physician or midwife not to try to make the determination if there is enough cord blood, but rather, have the sample submitted to us so our lab can determine exactly how many viable stem cells we can recover and whether it is enough to save.

7. How quickly are the stem cells processed following collection?

The longer it takes to process your stem cells, the fewer cells will be viable for storage. Most cord blood banks process the stem cells 24-72 hours after collection.

MiracleCord offers very fast processing time, with our average coming in at about half the time of most other cord blood banks. Our TimeCritical® Processing helps yield significantly more viable stem cells.

8. What method is used to process the cord blood and cord tissue?

How the cells are processed is important because we want to capture as many viable stem cells as possible.

MiracleCord has skilled, experienced laboratory technicians processing your baby’s cord blood and tissue stem cells. Our advanced processing methods result in cell recovery rates that are among the highest in the industry.

Our proprietary method of processing cord tissue saves all cell types, including mesenchymal, endothelial, epithelial, neuronal, hematopoietic, and perivascular. Our method of processing cord tissue mitigates the serious limitations of storing whole tissue and consistently yields recovery of high percentages of viable cells after cryopreservation.

9. Are the stem cells stored in a compartmentalized storage bag?

A compartmentalized bag is useful if you are using your stem cells for a clinical trial and may still want to have some on hand for future use.

MiracleCord uses a multi-compartment cryo-storage bag with five separate segments.

10. Where do you store the stem cells?

Determine where the lab is, and ensure it is accredited and has appropriate safeguards in the event of a power failure or natural disaster.

MiracleCord’s lab is located in Arizona and employs 24/7/365 multi-layer temperature monitoring and manifold emergency power sources, which include generator and battery back-up systems. Our storage facilities have some of the largest bulk nitrogen tanks in the country. In the event of a mass power outage, we can keep your child’s stem cells cryogenically frozen at the proper temperature for several weeks or more without power.

Pricing, Hidden Costs, and Guarantee

Understand what you’re paying for — and how to avoid surprises down the road.

11. What happens if I need to use my stem cells but already paid for long-term storage?

With most companies, you will not be reimbursed.

If you’ve chosen a prepaid 20-year or Lifetime plan with MiracleCord and need to use all of your stem cells before the end of the term, we will reimburse you for the time you already paid but didn’t use at the prorated storage amount. We don’t know of another company that offers this reimbursement.

12. What happens if my cord blood does not get collected or can’t be saved?

You’ll want to make sure you’re not on the hook for storage fees in the unlikely event you don’t end up storing your child’s cord blood.

With MiracleCord, there is a $200 deposit billed at the time of enrollment (covering costs associated with the StemCare® collection kit and shipping the kit to you) and the balance isn’t due until after the stem cells are received and processed at our lab. If we don’t receive the kit at our lab, or the sample(s) are not fit for processing and storage, we won’t bill for the balance. The client is only responsible for the deposit.

13. Do you offer incentives to medical professionals to recommend you?

Many cord blood banks offer financial incentives to doctors and hospitals to recommend their services. The costs of these incentives — often subtly hidden so as not to appear as incentives — are ultimately paid for by the customer.

MiracleCord does not pay a national sales force to market to medical professionals, and that’s why we can offer the highest-quality services at lower prices than our competitors.

14. Do you offer a guarantee if my saved stem cells fail to engraft?

It’s important that your cord blood bank offers a guarantee that allows you to find an alternative stem cell source in the event of a failure to engraft. A Scientific American article dating back to 2014 put the cost to acquire a unit of cord blood between $35,000 and $40,000.

If your child’s cord blood unit is used in a stem cell transplant and the cells fail to engraft, MiracleCord will pay up to $100,000 towards the cost of procurement of an alternative stem cell source. This guarantee is one of the highest in the industry.

15. Do you offer cord blood banking discounts for return clients?

Many cord blood banks (including MiracleCord) offer discounts for repeat customers and discounts for multiple births. It’s important to save cord blood for all siblings because there are instances when a child’s disease cannot be treated by its own stem cells.

Allogeneic transplants (those from another person, ideally, a healthy sibling) are required when the patient’s disease has a genetic basis, such as sickle cell disease, cystic fibrosis, immune deficiency syndromes, bone marrow failure, lymphoma, and genetic metabolism disorders.

MiracleCord offers significant discounts for repeat customers as well as multiple births. Contact us for more information.

16. Is there a fee to access my stored stem cells?

Some cord blood banks charge a fee to access your stem cells, along with shipping charges.

With MiracleCord there is no cost to retrieve and or ship the stem cell unit(s) to a U.S. transplant hospital for the first use. For subsequent use, or if shipping outside the U.S., the client or their insurance would cover the shipping cost. To access stored stem cells, you need only contact us. We’ll walk you through the release forms needed and coordinate with your care team as part of our service for no additional fee.

17. Will you ever raise my annual storage fees?

Over the course of several decades or a lifetime, it’s not unreasonable to expect a periodic increase associated with increases in the costs of medical supplies, lab services, or storage. Some companies raise their annual storage fees every year or two.

So the question you really want to ask your cord blood bank is, how often have you raised annual storage fees in the last 5 years? 10 years? 15 years?

MiracleCord has had only one annual storage fee increase in the last 15 years.

18. Is it important that a cord blood bank sponsor clinical trials?

Some of the other large cord blood banks promote the clinical trials or research they sponsor or support. We applaud their efforts to further the use of stem cells for life-saving treatments and believe ongoing stem cell research is important, but this research is going to continue whether sponsored by cord blood banks or not.

The question to ask is, does a bank’s sponsorship of a trial translate into access to such trials for their customers? Are their customers ultimately paying the costs of these sponsorships regardless of their service fees?

It’s worth noting that a large percentage of the stem cells donated to public cord blood banks are sold for research. There is a great deal of research into stem cell transplant applications, with thousands of clinical trials already initiated.

MiracleCord is always looking to find new treatment opportunities for stem cells, but we do not financially support these clinical trials in the interest of keeping our service fees as low as possible.

Red Flags

The cord blood banking industry is full of providers, large and small, ethical and …not-so-much. Here are a few of the red flags to watch out for when choosing your cord blood bank:

1. The cord blood bank offers placental tissue banking

If you find a cord blood bank that offers placental tissue banking, we urge you to steer clear of them. Here’s why:

Cord tissue and placental tissue both contain mesenchymal stem cells (MSCs). MSCs can differentiate into many kinds of cells, including skin, bone, fat, muscle, cartilage and organ cells, and thus represent the most cutting-edge discoveries in regenerative medicine today. MSCs have also been shown to suppress the body’s immune response so doctors sometimes use them in addition to HSCs collected from cord blood to mitigate transplant rejection.

The best place to harvest MSCs is in the cord tissue. It is far more difficult to extract MSCs from the placenta due to cross-contamination with the mother’s cells, and it’s an unnecessary expense (a gimmick, really), because we have the ability to expand MSCs captured from cord tissue by thousands of times, providing a virtually unlimited supply. So placental tissue banking adds to the cost for no additional benefit.

2. The cord blood bank has hidden fees

Many cord blood banks seem to offer low costs but actually add significant fees to their advertised pricing midway through the enrollment process. For example, one competitor charges an additional $250 for medical courier, $59 for a multi-compartment cryogenic-bag, and $39 for weekday overnight shipping of the collection kit to the client. These services are all included in MiracleCord’s pricing.

3. The cord blood bank has low monthly fees, but they are new and have no experience

If it sounds too good to be true, it probably is. There are some new companies in the marketplace trying to lure customers with low monthly fees for their storage plans. We can say from experience that these plans with low monthly fees will wind up costing you a lot more in the long run.

Also, it’s important that the company you choose will be in business for a long time to come, and the financial stability of these new companies, as well as the quality of service provided, is questionable.

The Bottom Line

You only get one chance to save your newborn’s cord blood or tissue, and the company you choose will be your family’s safety net for many years to come. When choosing a cord blood bank, price is important, but value for your investment is even more important.

We believe MiracleCord offers the best of both worlds: the industry’s best pricing and the best overall value. That’s one reason why we were awarded Best U.S. Cord Blood Bank by Global Health & Pharma, an independent biotech rating organization, in 2021 and again in 2022.

Download our Free Info Kit to learn more or contact us at 888.743.2676 to speak to a customer service representative.

Here's what you need to know now.

DISCLAIMER: THE INFORMATION ON THIS WEBSITE IS NOT INTENDED TO BE USED AS MEDICAL ADVICE. The materials and information contained on the MiracleCord website is provided for educational and informational purposes only, and is not intended to, and does not constitute, medical or other health advice or diagnosis, and should not be used as such. You should not use this information to diagnose or treat a health problem or disease. If you are seeking personal medical advice, you should consult with a licensed physician. Always consult with a qualified health care provider regarding a medical condition.

Mark Locascio is the Founder and CEO of MiracleCord. Recognized in 2022 as one of Illinois’ top 32 biotech CEOs, he has spent nearly two decades making cord blood banking accessible to families nationwide.

Related Posts

Client Agreement

MiracleCord, Inc. (“MiracleCord”) is a provider of services for the collecting, testing, processing, cryopreserving and storing of cells collected from a newborn’s umbilical cord blood (“Cord Blood”) as well as certain umbilical cord tissue (“Cord Tissue”), (individually a “Neonatal Specimen” or collectively “Neonatal Specimens”). This Client Agreement (“Agreement”) explains MiracleCord’s obligations to you (“Client”) and your agreements with MiracleCord, and to ensure, where applicable, that where there is a birth mother other than Client (e.g., a surrogate, gestational carrier or birth mother placing a baby for adoption – referred to herein as a “Birth Mother”) consents to the terms of this Agreement and the obligations that may then reside with the Birth Mother per the Agreement.

MiracleCord’s Obligations
1. MiracleCord shall provide to the Client (or to the Birth Mother, when applicable) a collection kit for the Client or Birth Mother to bring to the hospital or other birth location for the collection of the Client’s newborn baby’s Cord Blood and/or Cord Tissue, and a maternal blood sample (collectively “Specimens”). MiracleCord shall include with the collection kit reasonable directions for the attending medical professional for the use of the kit and the collection of the Neonatal Specimens.
2. As soon as possible after the Specimens have been collected, the Client (or the Birth Mother, when applicable) will contact MiracleCord’s medical courier partner (“Courier”) to request pick up. The Courier will pick up the Specimens at the birth location and deliver them to MiracleCord’s laboratory partner (“Lab”).
3. Upon arrival at the Lab certain tests will be conducted on the Specimens.
4. The Neonatal Specimens will be uniquely identified, stored, and maintained at a cryogenic storage facility, and shall remain in cryopreserved storage for the full period of the Agreement between MiracleCord and Client or until the Agreement is terminated as provided for in this Agreement.
5. MiracleCord reserves the right to transfer the Neonatal Specimens, at its cost, during the term of this Agreement.
6. Upon receipt by MiracleCord of a written request from the Client, MiracleCord shall arrange for some or all of the Neonatal Specimens (as requested by the Client) to be transported directly to a physician appropriately qualified to perform a transplant or medical procedure (“Physician”), or to a medical care facility, to be used in a medical procedure as determined by Client and Client’s physician, subject to FDA guidelines. Except as otherwise provided in this Agreement, MiracleCord shall not transport the Neonatal Specimens from the storage facility to any party, including Client, other than to a physician or medical care facility for a medical procedure. The initial transportation within the United States of the Neonatal Specimen(s) as provided herein shall be at MiracleCord’s expense. A subsequent transportation of the Neonatal Specimen(s) within the United States, or the transportation of the Neonatal Specimen(s) outside of the United States shall be at Client’s expense.
7. Upon termination of this Agreement for storage of the Neonatal Specimens between MiracleCord and the Client, MiracleCord will transport, at Client’s cost, the Neonatal Specimens to a physician, medical care facility or appropriately accredited or licensed cryopreservation laboratory/storage facility, as directed by Client and subject to all applicable laws and regulations. Such direction shall be in the form of a document provided to Client that shall be executed, notarized and returned to MiracleCord. Alternatively, at Client’s direction (in accordance with the preceding), or if no direction is provided by Client within sixty (60) days after termination, MiracleCord or the Lab will dispose of the Specimens in an appropriate manner, including but not limited to transfer to a research facility.

Client’s Obligations
1. The Client will carefully read and execute this Agreement and ensure the Client (and Birth Mother, where applicable) has completed the Health History Profile and the “Parent” section of the Collection Worksheet provided by MiracleCord. The Client is encouraged to have the documentation related to the collection, testing, processing and storage of the Specimens reviewed by Client’s counsel and medical professional of Client’s choosing.
2. As provided for in this Agreement and for avoidance of any doubt, if the Client executing this Agreement is not the Birth Mother of the child whose Neonatal Specimens are being collected, the Client will obtain the written consent of the Birth Mother to all of the applicable terms and conditions in this Agreement by having her sign this Agreement.
3. The Client will select the medical facility and medical professional that will conduct the collection of the Neonatal Specimens. The Client acknowledges the selection of the medical facility and the medical professional is solely the responsibility of the Client and that MiracleCord does not select or otherwise determine who shall perform these services.
4. Client agrees to notify the medical professional and the medical facility staff of the desire to collect the baby’s Cord Blood (and Cord Tissue if applicable).
5. As soon as possible after collection of the Specimens, the Client or Birth Mother will call the Courier to request pick up of the Specimens for delivery to the Lab.
6. If the checkbox in the top section of the “Parent” section on the Collection Worksheet is not checked and the baby’s cord tissue sample arrives at the Lab, it will be processed and stored, and the Client will be billed for the applicable cord tissue fees.
7. The Client will make all payments in a timely manner.

Fees and Plans
1. At the time of initial enrollment of the Client to receive MiracleCord’s services, the Client will pay a non-refundable deposit of $200.00 (in the event of multiple births, the deposit will be $200.00 per baby). Upon collection of the Specimens, Client shall be obligated for the payment of the balance of the fees for the plan as selected by the Client. By accepting this Agreement, if the Client elects a financing arrangement for the fees, Client hereby accepts the Payment Plan Disclosure provided to Client via email, or if not provided by email, then on the MiracleCord website. Other terms and conditions may apply. Acceptance of the Client Agreement, including all of the terms and conditions herein, shall occur upon either (i) execution of this Agreement or (ii) payment of the non-refundable $200 deposit.
2. Upon accepting this Agreement, the Client will select one of the storage and payment plans that is on MiracleCord’s website for online enrollment. Storage plan options include an annual plan and long-term plan(s).
3. The annual plans include: (a) a separate fee for the initial service, which includes testing and processing of the Specimens, the transport of Specimens by the Courier to the Lab, and the collection kit for the Specimens, and (b) the storage fee for the first twelve months. Thereafter, the Client will be invoiced for additional annual storage fees. Annual storage fees will be charged automatically to the credit/debit card on file approximately fourteen (14) days before your baby’s birthday, unless you have chosen a long-term storage plan. Annual storage plan fees may be adjusted from time to time.
4. The long-term plans include: (a) a separate fee for the initial service, which includes testing and processing of the Specimens, the transport of Specimens by the Courier to the Lab, and the collection kit for the Specimens, and (b) the applicable storage fee for the period set forth in the specific long-term plan selected by the Client.
5. The Client will be charged a late fee equal to 10% of the amount due if any required fee is not paid when due. Additionally, any amount not paid within thirty (30) days of the date due shall accrue interest at the rate of 1.5% per month until paid.
6. As set forth above, there is no MiracleCord fee for an initial transfer of the Neonatal Specimen(s) that is retrieved by the Client to be used in an engrafting or transplant procedure within the United States. MiracleCord shall be responsible for any shipping or courier costs for an initial transfer of the Neonatal Specimen(s) for use in such medical procedure within the United States. The Client shall be responsible for any shipping or courier costs for any subsequent transfer of Neonatal Specimen(s), or for any transfer to any location outside of the United States. The fee to transfer the Neonatal Specimen(s) that is retrieved by the Client for any reason other than an engrafting or transplant procedure will be made available to Client by MiracleCord by contacting MiracleCord prior to requesting retrieval of the Neonatal Specimens.

Limitations of the Program
1. MiracleCord shall have no liability in the event of:
a. Failure of the medical professional to correctly collect, label or assemble the Specimens inside the collection kit;
b. Failure of the medical professional to attend to any medical issue that arises during the delivery of the newborn, even if such failure was due to such medical professional’s attention to collecting the Specimens;
c. Failure of the Courier to deliver the Specimens, due to loss or destruction of the Specimens while in the Courier’s possession;
d. Any contamination of the Specimens at the time of collection and up until the Specimens are delivered to the laboratory for further processing and testing;
e. Any event that harms or contaminates the Specimens that was beyond the reasonable control of MiracleCord, such as, fire, explosions, power outages, storms, floods, terrorism, wars, labor disputes, governmental action, imposition of statutes, laws or regulations that materially alter the program for collection, processing, testing and storage of the Specimens;
f. Any failure of an engrafting procedure or transplant of the Neonatal Specimens, except as provided in MiracleCord’s Quality Guarantee with respect to Cord Blood.
2. MiracleCord’s liability to the Client for any claims, loss, harm, damages, expenses, costs (including attorneys’ fees) shall be limited to a return of the fees paid by Client for MiracleCord’s services under this Agreement.
3. In the unlikely event a Neonatal Specimen is reasonably determined to be inappropriate for the program, MiracleCord will return to Client any storage fees paid by Client in advance, whether under any annual or long-term plan.
4. MiracleCord shall have no liability for, and Client hereby releases and discharges MiracleCord from any obligations with respect to, any disclosure of information in accordance with the Privacy Policy that is attached to this Agreement and/or provided on MiracleCord’s website.

Quality Guarantee
As a MiracleCord client, the viability of your baby’s umbilical cord blood stem cells is guaranteed by MiracleCord with respect to the initial stem cell transplant procedure. If, in an initial stem cell transplant procedure, your child’s Cord Blood stem cells fail to engraft, MiracleCord will pay up to one hundred thousand dollars ($100,000) toward the cost of procurement of an alternative stem cell source, if medically indicated. Cord Tissue is specifically excluded from the terms of this quality guarantee.
1. Definition of Engraftment – Stem cell engraftment is defined as three consecutive days in which the patient’s absolute neutrophil count is at least 500 per microliter, with the first of the three measurements occurring within 100 days of transplantation.
2. Quality Guarantee Medical Requirements:
a. The Cord Blood must have been collected with a MiracleCord collection kit and processed and cryogenically stored by the Lab, and cannot subsequently have been transferred to a storage facility other than a MiracleCord Lab;
b. The results of the testing by the Lab of the Cord Blood and maternal blood must show no evidence of infection or contamination;
c. The cells must be used in a stem cell transplant for hematopoietic reconstitution either by the donor (autologous) or by the donor’s biological parents or biological siblings;
d. The donor cells must be at least a 4 out of 6 HLA match to the recipient;
e. The Cord Blood unit must contain at least 2 x 107 total nucleated cells (TNC) per kilogram weight of recipient;
f. The Cord Blood unit must contain at least 1 x 105 CD34+ cells per kilogram weight of recipient;
g. The transplant facility must use a validated cord blood thawing procedure, and the cord blood stem cells must be administered immediately upon thawing;
h. The stem cells must be administered to the transplant recipient by a transplant physician, in a medical facility qualified by an Institutional Review Board (IRB) for stem cell transplantation;
i. The cells must not be subjected to manipulation, cell expansion, positive or negative cell selection, or gene therapy;
j. The patient must be given sufficient time (post-transplant) for engraftment to occur;
k. The stem cells must not be used in combination with supplemental stem cell sources, including, but not limited to, additional cord blood, peripheral blood, or bone marrow;
l. The stem cells must not be used in experimental procedures, including, but not limited to, mini-transplants, or other types of extensive and/or experimental laboratory cultures;
m. The stem cells and/or transplant recipient must not be subjected to an investigational drug within 100 days of transplantation.
3. Quality Guarantee Documentation Requirements:
a. Signed statement from the transplant physician attesting that engraftment did not occur;
b. Medical records documenting proof of non-engraftment;
c. Proof that all third-party payers responsible for payment of any fees associated with the collection, storage, or transplant of the Cord Blood have been notified of the existence of MiracleCord’s Quality Guarantee and the amount to be paid.
4. This Quality Guarantee is not available to:
a. Clients that reside in areas where this guarantee is prohibited by law, or in the event the transplant procedure is performed outside of the United States;
b. Clients whose cord blood banking fees or transplant fees are paid in full or in part by Medicare or Medicaid;
c. Clients whose cord blood banking fees (i) are paid in part or whole by third-party payers in Massachusetts and Michigan or (ii) have been waived or forgiven, in whole or in part, by MiracleCord prior to the request by the Client for transplant of the stem cells;
d. Clients who have an unpaid balance due to MiracleCord for services rendered;
e. Clients enrolled in MiracleCord’s Select Transplant Program.
f. Clients who have directed a transfer of the Neonatal Specimens to any location other than to a Physician or medical care facility for use in a transplant or medical procedure.
5. Your baby’s Cord Blood is not guaranteed to be a match for a family member, and an umbilical cord blood transplant may not provide the best course of treatment for any particular disease. Ultimately, the use of your child’s cord blood stem cells will depend on the physician’s determination of disease type and the HLA matching for donor and recipient.

Informed Consent
1. To confirm that the Client (a) understands the services to be provided by MiracleCord, and (b) has been informed of the processes and procedures that will be performed by MiracleCord or the Lab, the following provisions regarding the Client’s informed consent for such engagement and receipt of services is incorporated into this Agreement. The term “I”, as used in this informed consent provision, is a reference to the Client and, where different from the Client, the Birth Mother:

I acknowledge that I have decided and consented to have my baby’s Cord Blood and/or Cord Tissue (as applicable) collected after the birth of my baby and to have such Neonatal Specimens tested, processed, cryopreserved and stored. I also agree to provide samples of my own blood for testing. Although infrequent, I understand that at the time of childbirth complications may occur and attending to my health or the health of my newborn is the priority; therefore, it may not be possible to collect my baby’s Neonatal Specimens.

I acknowledge that it is my decision to select the medical professional that will attend to the birth of my baby and conduct related medical procedures, including the collection of my baby’s Neonatal Specimens. I understand that MiracleCord may contact the medical professional for the purposes of discussing MiracleCord’s services, and in certain cases, such medical professional may receive payment from MiracleCord for performing services related to the collection of my Specimens. In order to ensure and enhance the communications for my benefit between the hospital, medical professional and MiracleCord, I hereby authorize the hospital and medical professional to disclose my protected health information related to the collection of my Specimens with MiracleCord. MiracleCord may provide the hospital and medical professional with a copy of this authorization. I understand that I am entitled to be provided a copy of any disclosed information and that this authorization can be revoked at any time. I understand that MiracleCord will not use my protected health information for marketing or promotional purposes.

I understand that the Lab will perform tests on the Cord Blood, including cell viability, total nucleated cell count, CD34+, bacteria and fungus to determine the nature and quality of the Cord Blood, and the Lab will perform tests on the Cord Tissue (if collected), including cell viability and sterility, to determine the nature and quality of the Cord Tissue, and that my blood will be tested for certain infectious diseases including human immunodeficiency virus (HIV), hepatitis B and hepatitis C viruses, human T-lymphotrophic virus (HTLV), cytomegalovirus (CMV), and syphilis. I understand that if applicable law, regulations, certification requirements or industry standards are modified or amended, then alternative, additional or substitute tests may be performed. I acknowledge and consent to MiracleCord and the Lab making such reports of the results of these tests as required by applicable law.

I understand that MiracleCord may elect not to retain the collected Neonatal Specimens if, in MiracleCord’s reasonable judgment such Neonatal Specimen is not appropriate for storage. Such reasons may include, but are not limited to, if there is any condition that may affect the viability of the future use of such Neonatal Specimen. The final decision as to whether such Neonatal Specimen is appropriate for storage shall be that of MiracleCord and the Lab. I understand that I will be notified in writing of a decision that such Neonatal Specimen is not appropriate for either testing or storage, and such a determination shall result in the termination of any further obligations of either party under this Agreement.

I understand that there are potential benefits of Cord Blood and Cord Tissue for use in the treatment of certain diseases and conditions. I also understand that the limits of the longevity of storing Neonatal Specimens are not completely known. I acknowledge that it is not possible to know if transplanting Cord Blood or Cord Tissue stem cells will be effective in the treatment of any particular diseases or conditions. I understand that the Neonatal Specimens are a perfect match for my baby, and have been informed that, unless and until further testing is completed, it is not possible to know whether the Neonatal Specimens will be a match for any other particular individual. I understand that the collection of Specimens, and transplantation of Neonatal Specimens are medical procedures, and that there are inherent risks in any medical procedure. I acknowledge that MiracleCord does not and will not, perform, advise, or participate in any way in such medical procedures and will not have any liability for such medical procedures, and I release and discharge MiracleCord from any such liabilities.

Miscellaneous
1. Confidentiality – MiracleCord acknowledges the confidential nature of the Client’s information provided to MiracleCord (and the information about the Client’s child) and will use its reasonable best efforts to maintain the confidentiality of such information, except as may be required by applicable law. The Client agrees to the release of information by MiracleCord to any medical facility, hospital, laboratory or medical professional providing services to the Client that are related to the Specimens, including the provision of any engrafting or transplant procedures.
2. Termination by Client – This Agreement may be terminated by the Client (a) at any time prior to collection of the Specimens, or (b) after giving MiracleCord at least sixty (60) days prior written notice at any time after storage of the Neonatal Specimens. All fees paid through the date of termination are non-refundable.
3. Termination by MiracleCord – This Agreement may be terminated by MiracleCord (a) if MiracleCord has determined any such Neonatal Specimen is not appropriate for storage, in which case MiracleCord will return to Client any storage fees paid by Client in advance for such Neonatal Specimen, whether under any annual or long-term plan, (b) if Client does not timely pay any fee when due, or (c) at any time after giving Client at least sixty (60) days prior written notice of such termination, in which case MiracleCord will return to Client a pro rata portion of any storage fees paid in advance under any annual or long-term plan.
4. Upon termination of this Agreement by Client in accordance with Section 2 above, or by MiracleCord in accordance with Sections 3(a) or 3(c) above, and after storage has commenced, Client may request to retrieve the Neonatal Specimen and shall pay the applicable retrieval fee at such time. If either (a) pursuant to the preceding sentence, Client does not request retrieval of the Neonatal Specimen or (b) MiracleCord has terminated the Agreement in accordance with Section 3(b) above, MiracleCord, without liability, shall be free to use or dispose of such Neonatal Specimen in an appropriate manner, including but not limited to transfer to a public cord blood or tissue bank or to a research facility. Client hereby releases and discharges MiracleCord from any and all claims, liabilities, costs or actions that may arise out of or result from MiracleCord’s activity or handling of the Specimens after termination. In addition to the foregoing, MiracleCord shall be entitled to recover from Client all costs and fees (including reasonable attorney’s fees) incurred in any action to collect any amounts due from Client under this Agreement.
5. Consent to Communications – Client understands and agrees that MiracleCord and Client communications may occur in several different ways and means of communication. Client agrees that MiracleCord may communicate with Client by means of any of email, text messaging, telephone, or written communication. Client has the right to opt out of such communications by using that means of communication you wish to stop at any time: (i) an email to MiracleCord at [email protected]; (ii) a text “STOP” in response to a MiracleCord text; (iii) a call to MiracleCord customer services at 1-888-743-2673 or (iv) by letter to MiracleCord at 875 N Michigan Ave, Ste 3100, Chicago, IL 60611.
6. Notices – Any notice either required or permitted under this Agreement may be given (a) personally to the other party, (b) by private delivery services (e.g., Federal Express or UPS) with a return receipt requested, or (c) by United States registered or certified mail return receipt requested. Notice shall be sent to the other party at their last known address.
7. Dispute Resolution – In the event of any dispute between the Client (or Birth Mother where applicable) and MiracleCord with respect to this Agreement or related in any way to the collection, testing, processing and storage of the Specimens, or a dispute over any payments or fees, such dispute will be submitted to binding arbitration under the rules of the American Arbitration Association (the “AAA Rules”). The arbitration will be held in Chicago, Illinois before a single arbitrator. The fees of the arbitrator will be shared equally by the parties. Other than such arbitrator fees, the prevailing party in such arbitration, as determined by the arbitrator will be entitled to recover its costs and expenses of the arbitration. The arbitrator will issue a written opinion of his/her decision, and such decision will be binding, final and enforceable in any court of competent jurisdiction.
8. Governing Law – This Agreement and the relationship between the Client, the Birth Mother and MiracleCord shall be governed by and interpreted in accordance with the laws of the State of Illinois without regard to its choice of laws rules.
9. Assignment – Upon the attainment of the age of majority by the child from whom the Neonatal Specimens were collected (the age of majority as determined in the state of the domicile of the child, but in no event earlier than the age of majority in the State of Illinois), the Agreement between the Client and MiracleCord shall be assigned to such child who shall then be the Client hereunder. Additionally, if different from the initial Client, this Agreement shall be assigned to any guardian of the child from whom the Neonatal Specimens were collected. MiracleCord may assign its rights and obligations under this Agreement (i) to any acquirer of the majority of the stock of MiracleCord or substantially all of the assets of MiracleCord or (ii) in the unlikely event that, for any reason, MiracleCord ceases to be an ongoing concern, to ensure the uninterrupted provision of services, MiracleCord may assign its rights and obligations under this Agreement to the Lab. Except for the foregoing circumstances, neither the Client nor MiracleCord shall assign its rights and obligations under this Agreement without the prior written consent of the other party. All of the terms and conditions shall be binding on any successor or assign of a party.
10. Waiver – No waiver by any party with respect to any breach or default or of any right or remedy, and no course of dealing, shall be deemed to constitute a continuing waiver of any other breach or default or of any other right or remedy, unless such waiver is expressed in writing signed by the party to be bound by such waiver. Failure of a party to exercise any right, under this Agreement or at law or in equity, shall not be deemed a waiver of such right or rights in the future.
11. Severability – If any of these terms and conditions are held to be invalid or unenforceable, such invalidity or unenforceability will not affect the other terms and conditions, which will remain in full force and effect.
12. Entire Agreement – This Agreement, and the attachments to this Agreement, represent the entire agreement between the Client and MiracleCord and supersede any oral or written prior agreements, representations, or understandings.

The Client (and the Birth Mother, if different than the Client, and solely with regard to those provisions of this Agreement that are applicable to the Birth Mother) has indicated acceptance of this Agreement as of the date set forth below.

Client                                                                Birth Mother

__________________________________             __________________________________
Printed Name                                                    Printed Name

__________________________________             __________________________________
Signature                                     Date              Signature                                     Date

CLIENT RIGHTS
Medical care for the birth mother and baby is of the highest priority to MiracleCord. If the medical condition of the mother or baby becomes a concern, the collection process should be withdrawn. Under no circumstances should the collection process be completed if any medical care would be sacrificed to the mother or baby. The Client’s healthcare professional is responsible for identifying any circumstances that would put the mother or baby at risk. The Client also has the right to deny consent of the collection at any time without affecting access to medical care. Also, the Client has the right to have any and all questions answered concerning any part of the process, completion of the forms, testing for infectious diseases, and storage (this list is not all-inclusive).

PRIVACY POLICY
MiracleCord takes seriously its obligation to keep all personal and health information strictly confidential and to limit the disclosure of such information. Please read our Privacy Policy for more information.

CA0526.1

Privacy Policy

MiracleCord is committed to keeping the personal and health information you provide to us strictly confidential and to limit the disclosure of such information.

The Information

As a result of your enrollment as a Client of MiracleCord, you will be providing MiracleCord with various types of information. You will provide MiracleCord with personal identification information such as names, addresses, phone numbers and credit card numbers. You will also provide MiracleCord with a medical health history questionnaire that contains information about you. Included in “information” that is subject to this policy is any additional information you voluntarily provide to us.

You understand and agree that as a result of your use of this site and interest in MiracleCord that MiracleCord may communicate with you by means of any of email, text messaging, telephone or written communication. You have the right to opt out of such communications by using that means of communication you wish to stop at any time: (i) an email to MiracleCord at [email protected]; (ii) a text “STOP” in response to a MiracleCord text; (iii) a call to MiracleCord customer service at 1-888-743-2673; or (iv) by letter to MiracleCord at 875 N Michigan Ave, Ste 3100, Chicago, IL 60611.

MiracleCord’s Obligations of Confidentiality

With respect to the personal identification information you provide to us, MiracleCord will only disclose such information to its employees, agents, representatives and its service partners providing collection, testing and storage services related to the Specimens, and only where such individuals or entities have demonstrated a need to know for the purposes of completing the process of storing the Specimens as part of the program in which you have enrolled, and maintaining adequate records related to such storage. Without your consent, MiracleCord will not share or sell your information to any vendor, marketing or promotion firm or any other third party. One exception to this general commitment is that MiracleCord will comply with all applicable governmental orders or requirements as well as any judicial or other regulatory agency subpoenas. MiracleCord will notify you in the event it receives such order, requirement or subpoena.

With respect to the medical information you provide to MiracleCord, including your responses on the medical health history questionnaire and the results of any tests on the Specimens, MiracleCord will only disclose such information as required by applicable federal or state law. Additionally, MiracleCord may disclose such information to a third party for whom you have granted consent for such disclosure, including any medical professional providing health care services to you, your child or any third party. Any information related to the Specimens maintained by either MiracleCord or its service partners will be treated the same as medical information as described under this policy.